Phreesia (PHR) Stock Forecast & Price Target

Compare

303 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PHR Analyst Ratings

Strong Buy

10 Buy

0 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Phreesia

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PHR Stock 12 Month Forecast

Average Price Target

$32.50

▲(13.00% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Phreesia in the last 3 months. The average price target is $32.50 with a high forecast of $35.00 and a low forecast of $29.00. The average price target represents a 13.00% change from the last price of $28.76.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","36":"$36","21.75":"$21.8","26.5":"$26.5","31.25":"$31.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$32.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$29.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,21.75,26.5,31.25,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.34,27.006153846153847,27.672307692307694,28.338461538461537,29.004615384615384,29.67076923076923,30.336923076923078,31.003076923076925,31.66923076923077,32.33538461538461,33.00153846153846,33.667692307692306,34.33384615384615,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.34,26.813846153846153,27.287692307692307,27.76153846153846,28.235384615384614,28.709230769230768,29.183076923076925,29.65692307692308,30.130769230769232,30.604615384615386,31.07846153846154,31.552307692307693,32.026153846153846,{"y":32.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.34,26.544615384615383,26.74923076923077,26.953846153846154,27.158461538461538,27.363076923076925,27.567692307692308,27.77230769230769,27.976923076923075,28.181538461538462,28.386153846153846,28.59076923076923,28.795384615384616,{"y":29,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.92,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.67,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.71,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.36,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.47,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.1,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.16,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.23,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$32.50

Lowest Price Target$29.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Scott Schoenhaus

KeyBanc

$35

Buy

21.70%

Upside

Reiterated

08/22/25

KeyBanc Keeps Their Buy Rating on Phreesia (PHR)

Richard Close

Canaccord Genuity

$34

Buy

18.22%

Upside

Reiterated

08/12/25

Phreesia's Strategic Growth and Diversification: A Buy Rating Amidst Regulatory Challenges

Daniel Grosslight

Citi

$33→$34

Buy

18.22%

Upside

Reiterated

07/28/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Integer Holdings (NYSE: ITGR), Phreesia (NYSE: PHR) and Moderna (NASDAQ: MRNA)

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

07/28/25

Phreesia (PHR) Gets a Buy from Truist Financial

Anne Samuel

J.P. Morgan

―

Buy

―

Reiterated

06/25/25

J.P. Morgan Reaffirms Their Buy Rating on Phreesia (PHR)

John Ransom

Raymond James

$30

Buy

4.31%

Upside

Reiterated

05/29/25

Phreesia (PHR) Receives a Buy from Raymond James

Will Jellison

D.A. Davidson

―

Buy

―

Reiterated

05/29/25

Phreesia (PHR) Gets a Buy from D.A. Davidson

Ryan MacDonald

Needham

$29

Buy

0.83%

Upside

Reiterated

05/28/25

Phreesia's Strong Q1 2026 Performance and Resilient Outlook Justify Buy Rating

Ryan Daniels

William Blair

―

Buy

―

Reiterated

05/28/25

Phreesia's Strong Q1 Performance and Growth Prospects Justify Buy Rating

Jessica Tassan

Piper Sandler

$33

Buy

14.74%

Upside

Reiterated

05/28/25

Piper Sandler Sticks to Its Buy Rating for Phreesia (PHR)

Joseph Vruwink

Robert W. Baird

$34→$31

Buy

7.79%

Upside

Reiterated

04/08/25

Phreesia Inc. (PHR) PT Lowered to $31 at BairdBaird analyst Joe Vruwink lowered the price target on Phreesia Inc. (NYSE: PHR) to $31.00 (from $34.00) while maintaining a Outperform rating.

Glen Santangelo

Jefferies

$32

Buy

11.27%

Upside

Reiterated

03/25/25

Analysts Are Bullish on These Healthcare Stocks: Phreesia (PHR), Acrivon Therapeutics, Inc. (ACRV)

Aaron Kimson

Citizens JMP

$30

Buy

4.31%

Upside

Reiterated

03/13/25

Phreesia's Strong Market Position and Financial Performance Justify Buy Rating Amid Positive Outlook for FY 2026

Sean Dodge

RBC Capital

$24→$32

Buy

11.27%

Upside

Upgraded

01/08/25

RBC Capital upgrades Phreesia (PHR) to a Buy

Stephanie Davis

Barclays

$29

Buy

0.83%

Upside

Reiterated

10/02/24

Phreesia (PHR) Gets a Buy from Barclays

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Scott Schoenhaus

KeyBanc

$35

Buy

21.70%

Upside

Reiterated

08/22/25

KeyBanc Keeps Their Buy Rating on Phreesia (PHR)

Richard Close

Canaccord Genuity

$34

Buy

18.22%

Upside

Reiterated

08/12/25

Phreesia's Strategic Growth and Diversification: A Buy Rating Amidst Regulatory Challenges

Daniel Grosslight

Citi

$33→$34

Buy

18.22%

Upside

Reiterated

07/28/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Integer Holdings (NYSE: ITGR), Phreesia (NYSE: PHR) and Moderna (NASDAQ: MRNA)

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

07/28/25

Phreesia (PHR) Gets a Buy from Truist Financial

Anne Samuel

J.P. Morgan

―

Buy

―

Reiterated

06/25/25

J.P. Morgan Reaffirms Their Buy Rating on Phreesia (PHR)

John Ransom

Raymond James

$30

Buy

4.31%

Upside

Reiterated

05/29/25

Phreesia (PHR) Receives a Buy from Raymond James

Will Jellison

D.A. Davidson

―

Buy

―

Reiterated

05/29/25

Phreesia (PHR) Gets a Buy from D.A. Davidson

Ryan MacDonald

Needham

$29

Buy

0.83%

Upside

Reiterated

05/28/25

Phreesia's Strong Q1 2026 Performance and Resilient Outlook Justify Buy Rating

Ryan Daniels

William Blair

―

Buy

―

Reiterated

05/28/25

Phreesia's Strong Q1 Performance and Growth Prospects Justify Buy Rating

Jessica Tassan

Piper Sandler

$33

Buy

14.74%

Upside

Reiterated

05/28/25

Piper Sandler Sticks to Its Buy Rating for Phreesia (PHR)

Joseph Vruwink

Robert W. Baird

$34→$31

Buy

7.79%

Upside

Reiterated

04/08/25

Phreesia Inc. (PHR) PT Lowered to $31 at BairdBaird analyst Joe Vruwink lowered the price target on Phreesia Inc. (NYSE: PHR) to $31.00 (from $34.00) while maintaining a Outperform rating.

Glen Santangelo

Jefferies

$32

Buy

11.27%

Upside

Reiterated

03/25/25

Analysts Are Bullish on These Healthcare Stocks: Phreesia (PHR), Acrivon Therapeutics, Inc. (ACRV)

Aaron Kimson

Citizens JMP

$30

Buy

4.31%

Upside

Reiterated

03/13/25

Phreesia's Strong Market Position and Financial Performance Justify Buy Rating Amid Positive Outlook for FY 2026

Sean Dodge

RBC Capital

$24→$32

Buy

11.27%

Upside

Upgraded

01/08/25

RBC Capital upgrades Phreesia (PHR) to a Buy

Stephanie Davis

Barclays

$29

Buy

0.83%

Upside

Reiterated

10/02/24

Phreesia (PHR) Gets a Buy from Barclays

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Phreesia

1 Month

xxx

Success Rate

9/13 ratings generated profit

Average Return

+6.58%

reiterated a xxx

rating 26 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +6.58% per trade.

3 Months

xxx

Success Rate

9/14 ratings generated profit

Average Return

+6.82%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +6.82% per trade.

1 Year

Jailendra SinghTruist Financial

Success Rate

13/13 ratings generated profit

Average Return

+17.96%

reiterated a buy rating 26 days ago

Copying Jailendra Singh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +17.96% per trade.

2 Years

xxx

Success Rate

13/13 ratings generated profit

Average Return

+21.53%

reiterated a xxx

rating 26 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +21.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PHR Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PHR has received 7 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. PHR average Analyst price target in the past 3 months is 32.50.

Each month's total comprises the sum of three months' worth of ratings.

PHR Financial Forecast

PHR Earnings Forecast

Next quarter’s earnings estimate for PHR is -$0.06 with a range of -$0.14 to $0.03. The previous quarter’s EPS was -$0.07. PHR beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 33.33% of the time in the same period. In the last calendar year PHR has Preformed in-line its overall industry.

PHR Sales Forecast

Next quarter’s sales forecast for PHR is $116.50M with a range of $115.80M to $117.70M. The previous quarter’s sales results were $115.94M. PHR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.60% of the time in the same period. In the last calendar year PHR has Preformed in-line its overall industry.

PHR Stock Forecast FAQ

What is PHR’s average 12-month price target, according to analysts?

Based on analyst ratings, Phreesia’s 12-month average price target is 32.50.

What is PHR’s upside potential, based on the analysts’ average price target?

Phreesia has 13.00% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PHR a Buy, Sell or Hold?

Phreesia has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.

What is Phreesia’s price target?

The average price target for Phreesia is 32.50. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $29.00. The average price target represents 13.00% Increase from the current price of $28.76.

What do analysts say about Phreesia?

Phreesia’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of PHR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Phreesia (PHR) Stock Forecast & Price Target

PHR Analyst Ratings

PHR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Phreesia

PHR Analyst Recommendation Trends

PHR Financial Forecast

PHR Earnings Forecast

PHR Sales Forecast

PHR Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts